News from NORD

FDA Awards 21 Grants for Rare Disease Product Development

Publish date: November 7, 2016

 

New clinical research grants totaling more than $23 million have been awarded to support the development of diagnostics and treatments for patients with rare disease. More than 40% of the awards focus on treatments for children. The grants were awarded to investigators from academia and industry in the US and abroad through the FDA’s Office of Orphan Product Development.

Recommended Reading

Congenital Zika syndrome includes range of neurologic abnormalities
MDedge Neurology
NIH Issues Final Rule for Registering Clinical Trials and Reporting Results
MDedge Neurology
Penn State Graduate Student Hopes to Help Families Find NORD at Time of Rare Disease Diagnosis
MDedge Neurology
AT Children’s Project Advisors Elected to National Academy of Sciences
MDedge Neurology
What Are New and Potential Therapies for Neuromuscular Disorders?
MDedge Neurology
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
MDedge Neurology
Follow-Up of Infants With Zika Virus Identifies Several Neurologic Impairments
MDedge Neurology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Neurology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Neurology
Certification in Rare Neuroimmunologic Disorders
MDedge Neurology